Medtronic, Inc.; Premarket Approval of the CapSureFixRegister Pacing Lead, Model 4068

Riepilogo

The Food and Drug Administration (FDA) is announcing its approval of the application by Medtronic, Inc., Minneapolis, MN, for premarket approval, under the Federal Food, Drug, and Cosmetic Act (the act), of the CapSureFix Pacing Lead, Model 4068. FDA's Center for Devices and Radiological Health (CDRH) notified the applicant, by letter of March 29, 1996, of the approval of the application.